– TNG462 granted Orphan Drug Designation for treatment of pancreatic cancer –
Tango Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Highlights
Seeking Alpha / 5 hours ago 2 Views
Seeking Alpha / 5 hours ago 2 Views
– TNG462 granted Orphan Drug Designation for treatment of pancreatic cancer –
Comments